Evidence map›Paper›PMID 32174148›Full record

ArticleCell transplantation

In Vivo and In Vitro Evaluation of a Novel Hyaluronic Acid-Laminin Hydrogel as Luminal Filler and Carrier System for Genetically Engineered Schwann Cells in Critical Gap Length Tubular Peripheral Nerve Graft in Rats.

Nina Dietzmeyer, Zhong Huang, Tobias Schüning, Shimon Rochkind, Mara Almog, Zvi Nevo, Thorsten Lieke, Svenja Kankowski, Kirsten Haastert-Talini

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Rabbit Model for Peripheral Nerve Reconstruction Studies Avoiding Automutilation Behavior.Journal of brachial plexus and peripheral nerve injury · 2022
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Nina DietzmeyerInstitute of Neuroanatomy and Cell Biology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-3835-7606
Zhong HuangInstitute of Neuroanatomy and Cell Biology, Hannover Medical School, Hannover, Germany.
Tobias SchüningInstitute of Neuroanatomy and Cell Biology, Hannover Medical School, Hannover, Germany.
Shimon RochkindResearch Center for Nerve Reconstruction, Department of Neurosurgery, Tel-Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
Mara AlmogResearch Center for Nerve Reconstruction, Department of Neurosurgery, Tel-Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
Zvi NevoDepartment of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Thorsten LiekeTransplant Laboratory, Department of General-, Visceral-, and Transplantation Surgery, Hannover Medical School, Hannover, Germany.
Svenja KankowskiInstitute of Neuroanatomy and Cell Biology, Hannover Medical School, Hannover, Germany.
Kirsten Haastert-TaliniInstitute of Neuroanatomy and Cell Biology, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DETel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current study we investigated the suitability of a novel hyaluronic acid-laminin hydrogel (HAL) as luminal filler and carrier system for co-transplanted cells within a composite chitosan-based nerve graft (CNG) in a rat critical nerve defect model. The HAL was meant to improve the performance of our artificial nerve guides by giving additional structural and molecular support to regrowing axons. We filled hollow CNGs or two-chambered nerve guides with an inserted longitudinal chitosan film (CNG[F]s), with cell-free HAL or cell-free HA or additionally suspended either naïve Schwann cells (SCs) or fibroblast growth factor 2-overexpressing Schwann cells (FGF2-SCs) within the gels. We subjected female Lewis rats to immediate 15 mm sciatic nerve gap reconstruction and comprehensively compared axonal and functional regeneration parameters with the gold standard autologous nerve graft (ANG) repair. Motor recovery was surveyed by means of electrodiagnostic measurements at 60, 90, and 120 days post-reconstruction. Upon explantation after 120 days, lower limb target muscles were harvested for calculation of muscle-weight ratios. Semi-thin cross-sections of nerve segments distal to the grafts were evaluated histomorphometrically. After 120 days of recovery, only ANG treatment led to full motor recovery. Surprisingly, regeneration outcomes revealed no regeneration-supportive effect of HAL alone and even an impairment of peripheral nerve regeneration when combined with SCs and FGF2-SCs. Furthermore, complementary in vitro studies, conducted to elucidate the reason for this unexpected negative result, revealed that SCs and FGF2-SCs suspended within the hydrogel relatively downregulated gene expression of regeneration-supporting neurotrophic factors. In conclusion, cell-free HAL in its current formulation did not qualify for optimizing regeneration outcome through CNG[F]s. In addition, we demonstrate that our HAL, when used as a carrier system for co-transplanted SCs, changed their gene expression profile and deteriorated the pro-regenerative milieu within the nerve guides.

Indexed as

AnimalsAxonsChitosanHyaluronic AcidHydrogelsLamininNerve RegenerationPeripheral NervesRatsSchwann CellsSciatic NerveChitosanHyaluronic AcidHydrogelsLaminincellular drug delivery systemchitosanfibroblast growth factor 2Schwann cellssciatic nerve regeneration

Identifiers

PMID32174148
PMCPMC7444218
OpenAlexW3012320335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.